The growth of the market is due to growing focus on interventional radiology and nuclear medicine and rising cases of cancer demanding radiation therapy. However, organizational challenges and lack of benchmarking for dose optimization is expected to restrict the market growth during the forecast period.
Rapid advances in medical technology, device manufacturing, and imaging equipment have resulted in the refinement of original procedures with better techniques and an expansion of the indications for procedures. New techniques have been developed, and some techniques are migrated to other imaging modalities. More interventional radiological and nuclear medicine procedures are performed worldwide with high imaging efficiency. These procedures use high doses of radiation, and a longer duration may increase the risk of cancer in patients undergoing these procedures.
As reported by the World Nuclear Association, more than 10,000 hospitals worldwide use radioisotopes in medicine, and 90% of radioisotope procedures are diagnostic.
Market players, such as Bayer Healthcare and Sectra Medical Systems, offer dose management software specifically for RDM in interventional imaging and nuclear medicine. Although CT applications account for a larger share of the radiation dose management market, interventional radiology and nuclear medicine applications are expected to provide significant growth opportunities in the near future.
The Asia Pacific radiation dose management market, by service or software, is segmented into radiation dose management services and radiation dose management software. The Asia Pacific radiation dose management market, by medium, is segmented into computed tomography, radiation, and mammography, fluroscopy and mammography, and other medium. Based on end user, the Asia Pacific radiation dose management market is segmented hospitals, research and medical institutes, others. Geographically, the Asia Pacific radiation dose management market can be divided into China, Japan, India, South Korea, Australia and Rest of Asia Pacific.
FUJIFILM Holdings Corporation, Bayer AG, Bracco Imaging S.p.A, GE Healthcare, Koninklijke Philips N.V., Medsquare, Novarad Corporation, Sectra AB and PACSHealth, LLC are among the leading companies operating in the Asia Pacific radiation dose management market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 35.57 Million |
| Market Size by 2028 | US$ 82.09 Million |
| CAGR (2021 - 2028) | 12.7% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Service/Software
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia Pacific Radiation Dose Management Market is valued at US$ 35.57 Million in 2021, it is projected to reach US$ 82.09 Million by 2028.
As per our report Asia Pacific Radiation Dose Management Market, the market size is valued at US$ 35.57 Million in 2021, projecting it to reach US$ 82.09 Million by 2028. This translates to a CAGR of approximately 12.7% during the forecast period.
The Asia Pacific Radiation Dose Management Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Radiation Dose Management Market report:
The Asia Pacific Radiation Dose Management Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Radiation Dose Management Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Radiation Dose Management Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Radiation Dose Management Market
